Accepted Manuscript A canine model of experimental infection with Cryptosporidium canis Zhaohui Cui, Heping Dong, Rongjun Wang, Fuchun Jian, Sumei Zhang, Changshen Ning, Longxian Zhang PII:
S0014-4894(18)30008-0
DOI:
10.1016/j.exppara.2018.09.019
Reference:
YEXPR 7617
To appear in:
Experimental Parasitology
Received Date: 9 January 2018 Revised Date:
22 June 2018
Accepted Date: 23 September 2018
Please cite this article as: Cui, Z., Dong, H., Wang, R., Jian, F., Zhang, S., Ning, C., Zhang, L., A canine model of experimental infection with Cryptosporidium canis, Experimental Parasitology (2018), doi: https://doi.org/10.1016/j.exppara.2018.09.019. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT
1
A canine model of experimental infection with Cryptosporidium canis
2
Zhaohui Cuia,b#, Heping Donga,b#, Rongjun Wanga,b, Fuchun Jiana,b, Sumei Zhanga,b,
4
Changshen Ninga,b, Longxian Zhanga,b*
RI PT
3
5 6
a
7
Zhengzhou 450002, China
8
b
9
China
M AN U
International Joint Research Laboratory for Zoonotic Diseases of Henan, Zhengzhou,
10
15
EP
14
These authors contributed equally to this work.
AC C
13
#
TE D
11 12
SC
College of Animal Science and Veterinary Medicine, Henan Agricultural University,
16
*Corresponding author. Longxian Zhang, College of Animal Science and Veterinary
17
Medicine, Henan Agricultural University, No. 15 University Distract, Zhengdong Newly-
18
developed Area, Zhengzhou 450046, China.
19
Tel.: 86-371-56990163; Fax: 86-371-56990163;
20
E-mail:
[email protected];
[email protected].
21 1
ACCEPTED MANUSCRIPT
ABSTRACT
23
Cryptosporidium is a genus of protozoal parasites that affects the gastrointestinal
24
epithelium of a variety of hosts. Several models of experimental infection have been
25
described to study the susceptibility, infectivity and pathogenicity among different
26
Cryptosporidium species and isolates. This study aimed to establish an experimental
27
infection of Cryptodporidium canis in canids. Infectivity and pathogenicity have been
28
measured by evaluating the clinical status, pattern of oocyst excretion and histological
29
examination. Results showed that C. canis was not infective for immunocompetent dogs
30
or mice with severe combined immunodeficiency syndrome (SCID). Oocysts were first
31
detected in the feces of immunosuppressed dogs on day 3 post-infection (p.i.), with levels
32
peaking twice on days 10 and 17 p.i. during the patent period. cryptosporidial
33
developmental stages were found in the duodenum and jejunum of dogs in histological
34
sections stained with hematoxylin and eosin (H & E) and using scanning electron
35
microscopy (SEM). Histopathological changes in the intestinal tract of infected dogs
36
were characterized by epithelial metaplasia and dilatation; the integrity of intestinal
37
mucosal epithelial cells was distinctly damaged with whole sheets of cilia sloughed away.
38
Ultrastructural observation data were consistent with histological observations. Based on
39
these findings, the canine model described in this work will be useful to evaluate clinical,
40
parasitological and histological aspects of C. canis infection and will be useful for the
41
further understanding of cryptosporidiosis, drug development, and vaccine development.
42
Keywords: Cryptosporidium canis; Canine model, Experimental infection
AC C
EP
TE D
M AN U
SC
RI PT
22
2
ACCEPTED MANUSCRIPT
43 44
1. Introduction Cryptosporidium is a protozoal parasite that infects a variety of hosts, including humans, domestic and wild animals, worldwide (Ryan et al., 2016). Cryptosporidiosis
46
characteristically results in watery diarrhea, but clinical symptoms can vary from
47
asymptomatic shedding of oocysts to severe and life-threatening disease, depending on
48
the immune status of the host (Bouzid et al., 2013). Immunocompetent individuals
49
typically experience self-limiting illness (up to 2 to 3 weeks in duration) and recover
50
without treatment. However, in immunocompromised patients, cryptosporidiosis can
51
result in intractable diarrhea and may even be fatal in some cases (Chalmers and Davies,
52
2010). An effective vaccine or drug treatment for cryptosporidiosis is not yet available.
SC
M AN U
Dogs have been considered to be faithful friends and shared a close relationship with
TE D
53
RI PT
45
humans for over 10,000 years. Pet ownership has been recognizably proven to exert
55
beneficial effects on human health, by improving physical condition as well as mental
56
and emotional well-being (Hodgson et al., 2015). Consequently, pets are being
57
increasingly used as a therapeutic option in healthcare facilities (Wells, 2007). However,
58
dogs may not only act as intimate companions of humans but also as natural reservoirs of
59
a large number of zoonotic pathogens, including Cryptosporidium spp. (Chomel, 2014;
60
Esch and Petersen, 2013).
61
AC C
EP
54
Cryptosporidiosis has been reported in dogs worldwide (Jian et al., 2014). Currently,
62
four species of Cryptosporidium, namely C. canis, C. parvum, C. muris, and C.
63
meleagridis, have been detected in dogs (Lupo et al., 2008; Yoshiuchi et al., 2010; Scorza 3
ACCEPTED MANUSCRIPT
et al., 2011). Cryptosporidium canis causes the vast majority of infections in dogs (Ryan
65
et al., 2014) and is considered to be potentially zoonotic due to its presence in human
66
patients in a number of countries (Fayer, 2010; Gatei et al., 2008; Elwin K et al., 2012).
67
RI PT
64
Over the decades, different models of experimental infection have been described to study the susceptibility, infectivity and pathogenicity of Cryptosporidium (Ayinmode et
69
al., 2017; Kvac et al., 2013; Modry et al., 2012; Masuno et al., 2014; Petermann et al.,
70
2014). Nevertheless, information on cryptosporidiosis caused by C. canis infection in an
71
experimental host has yet been reported.
M AN U
72
SC
68
In this study, we developed a canine model of cryptosporidiosis caused by experimental infection with C. canis parasites. We analyzed the infectivity of C. canis
74
using severe combined immunodeficiency (SCID) mice and immunosuppressed dogs,
75
and described the clinical, parasitological, and histological aspects of experimental
76
infection in immunosuppressed dogs, which provide a good model for the future testing
77
of novel drugs or vaccines against cryptosporidisis.
EP AC C
78
TE D
73
79
2. Materials and methods
80
2.1. Ethics approval and consent to participate
81
This study was conducted in accordance with the Chinese Laboratory Animal
82
Administration Act (1988). The experimental protocol was approved by the Institutional
83
Animal Care and Use Committee of Henan Agricultural University (authorization number
84
IACUC-henau-20070503). 4
ACCEPTED MANUSCRIPT
85 86
2.2. Inoculum Cryptosporidium oocysts were obtained from a dog located in a pet hospital at the province of Henan, China. Oocysts were concentrated using the water ether technique
88
(Bukhari and Smith, 1995), and purified by discontinuous sucrose density centrifugation
89
(Heyman et al., 1986). Oocysts were counted using a Neubauer hemocytometer. A
90
combination of streptomycin and penicillin was added and this oocyst suspension was
91
kept at 4°C. C. canis oocysts for morphometry analyses were determined using digital
92
analysis of images (Motic Images Plus 2.0 soft-ware). Length and width of oocysts (n =
93
50) were measured under bright-field microscopy at 1000-fold magnification, and these
94
were used to calculate the length-to-width ratio of each oocyst.
M AN U
SC
RI PT
87
TE D
95
Total DNA was extracted using an E.Z.N.A.® Stool DNA Kit (OMEGA Biotek Inc.,
97
Norcross, GA, USA). To determine the species of Cryptosporidium for the isolate used in
98
this study, nested PCR protocols were used to amplify the SSU rRNA gene, actin gene
99
and HSP70 gene according to the previously-reported studies (Xiao et al.,1999; Sulaiman
AC C
EP
96
100
et al., 2002; Sulaiman et al., 2000). DNA sequencing indicated that the SSU rRNA and
101
HSP70 nucleotide sequences had a 100% similarity with C. canis (GenBank accession
102
number AB210854 and AY120920, respectively), while the actin nucleotide sequence had
103
a 99% similarity with C. canis (GenBank accession number AY120927). The nucleotide
104
sequences obtained in this study has been deposited in the GenBank database under
105
accession numbers: EU754826, EU754835 and EU754843. 5
ACCEPTED MANUSCRIPT
106 107
2.23. Experimental animals Six 8-week old SCID mice were obtained from Shanghai SLAC Laboratory Animal
109
Co., Ltd., Shanghai, China. All mice were housed individually in plastic cages with wire
110
mesh tops, under pathogen-free conditions, and kept on daily 12 h cycles of light and
111
dark. Mice received sterilized food and water, and were randomly divided into control and
112
test groups with 3 mice per group. Each mouse in the test group was inoculated orally by
113
a stomach tube with a dose of 1×106 oocysts.
SC
M AN U
114
RI PT
108
Nine beagle dogs, 7 weeks of age, were obtained from the Animal Lab Center of Henan Agricultural University. All dogs were confirmed to be free of C. canis infection
116
by microscopic examination of feces. During the adaptation period, dogs were vaccinated
117
against regional infectious diseases (Canine distemper, Parvovirus, Canine hepatitis,
118
Leptospirosis, and Rabies). Animals received commercial dog food, according to their
119
physiologic development, and water ad libitum.
EP
TE D
115
Experimental dogs (n = 3) were immunosuppressed according to the protocol as
121
described previously (Young et al., 2002). Dogs were fed 6 mg of dexamethasone acetate
122
per day for 5 days before infection. At day 8 of immunosuppression, each dog was
123
inoculated orally by a stomach tube with a dose of 1×106 oocysts. The following two
124
control groups were also included: immunocompetent dogs inoculated orally with 1×106
125
oocysts of C. canis (n = 3), and immunocompetent, non-inoculated dogs (n = 3). At days
AC C
120
6
ACCEPTED MANUSCRIPT
126
12 and 28 post infection (p.i.), one dog per group was euthanized by an intravenous
127
injection of a lethal dose of pentobarbital 100 mg/kg and their organs were removed.
129
RI PT
128
2.34 Clinical status
Dogs were examined daily for clinical signs including rectal temperature, respiratory
131
rate, and heart rate. Additionally, the presence of diarrhea and any abnormal behaviours
132
were observed.
M AN U
SC
130
133 134 135
2.45. Oocyst excretion
To determine the prepatent period, daily fecal samples were collected from each mouse and dog from day 1 to 28 p.i. Briefly, 1g of the feces from each animal was
137
examined using the Sheather’s sugar floatation method and counted using hemocytometer
138
slide under bright-field microscopy at 400-fold magnification. Repeat the count three
139
times and calculate the average. Infection intensity was determined by the number of
140
oocysts per gram (OPG). The OPG was estimated on the basis of number of oocysts
141
counted.
143
EP
AC C
142
TE D
136
2.56. Histological examination
144
For histological analysis, tissue samples harvested from duodenum, jejunum, ileum,
145
cecum, stomach, lungs, liver, spleen and kidney were fixed in 10% buffered formalin for
146
24 h, dehydrated in absolute ethanol, cleared in xylene, and embedded in paraffin. Tissue 7
ACCEPTED MANUSCRIPT
147
sections were stained with hematoxylin and eosin (H & E), and observed microscopically
148
at 400x and 1000x magnification. Tissue samples harvested from duodenum, jejunum, ileum and cecum were also
RI PT
149
prepared for scanning electron microscopy (SEM). Samples were fixed in 2.5%
151
glutaraldehyde for one week at 4 , and then washed with 0.1 mol/L phosphoric acid
152
buffer (pH = 7.4) three times for 10 min each. The dehydration procedure followed
153
conventional methods in a graded ethanol series of 30%, 50%, 70%, 90%, 100%, and two
154
more changes of 100%, each for 5 min followed by 50% isoamyl acetate solution (v/v,
155
isoamyl acetate: ethanol = 1:1) and 100% isoamyl acetate solution for 10 min,
156
respectively. After specimens were critically point-dried using CO2 and coated with gold,
157
observations were made by an S-3400 SEM (HITACHI).
158
3. Results
160
3.1. Clinical status
162 163
The appetites and attitudes of experimental and control SCID mice were normal
AC C
161
EP
159
TE D
M AN U
SC
150
until the end of the experiment. No diarrhea was observed in any mice. All immunosuppressed dogs inoculated with oocysts of C. canis showed signs of
164
physical deterioration, exhibiting loss of sheen to the coat, loss of interest in the
165
environment, and lethargy. These dogs began to have diarrhea around day 8 p.i. No
166
diarrhea was observed in any control group dogs. No animals died during the experiment.
167 8
ACCEPTED MANUSCRIPT
168
3.2. Oocyst shedding Fecal examination of infected dogs revealed fully sporulated C. canis oocysts only
170
in immunosuppressed dogs inoculated with C. canis oocysts. No Cryptosporidium
171
oocysts were found in control or non-immunosuppressed dogs during the experiment.
172
Likewise, no Cryptosporidium oocysts were detected in the feces of SCID mice in either
173
group. C. canis oocysts found were ovoid, and 4.8 (4.2-5.2) µm x 4.4 (4.2-5.3) µm (n =
174
50) (Fig. 1). Oocysts were first detected in feces on day 3 p.i., peaking twice on days 10
175
and 17 p.i. The patterns of oocyst shedding in dogs in the test group are presented in Fig.
176
2. Sequences of SSU rRNA gene, actin gene and HSP70 gene from experimentally
177
infected dogs shared 100% identity with the isolate used in the inoculum.
M AN U
SC
RI PT
169
179
TE D
178
3.3. Histological observations of sites of C. canis infection Cryptosporidial infection in immunosuppressed dog (at 12 days p.i.) was found in
181
the duodenum (Fig. 3A) and jejunum (Fig. 3B, C). However, no cryptosporidial
182
developmental stages or pathologic changes were observed at any other anatomic sites,
183
including the ileum (Fig. 3D), cecum, colon, or stomach. Likewise, no cryptosporidial
184
developmental stages or pathologic changes were observed at any anatomic sites in dogs
185
of control groups (data not shown). Histopathological changes in the intestinal tract of
186
dogs with cryptosporidiosis were characterized by epithelial metaplasia and dilatation;
187
the integrity of intestinal mucosal epithelial cells had been distinctly damaged, with
188
whole sheets of cilia sloughed away. These changes were more pronounced in the middle
AC C
EP
180
9
ACCEPTED MANUSCRIPT
189
and lower parts of duodenal mucosa epithelium, and the anterior and middle portions of
190
jejunal mucosa epithelium.
192
RI PT
191
3.4. Ultrastructural observation
Scanning electron microscopy study showed that C. canis at various of
194
developmental stages had adhered to the surface of the duodenum and jejunum in
195
immunosuppressed dogs. Epithelial cell surfaces were swollen and disordered (Fig. 4A,
196
B). The integrity of mucosal layer of the duodenum and jejunum had been damaged, and
197
many cilia had fallen off or atrophied (Fig. 4C, D). Ultrastructural observation also
198
showed that no parasites were observed in the ileum, cecum, colon, or stomach,
199
consistent with the histological observations described above.
200 201
4. Discussion
TE D
M AN U
SC
193
The potential role of companion animals as reservoirs for zoonotic diseases has been
203
recognized as a significant public health problem worldwide (Traub et al., 2005). Canids
204
(wild and domestic) are recognized as the main reservoir of a vast range of parasites.
205
Therefore, many studies with respect to Leishmania, Trypanosoma cruzi, Neospora
206
caninum and Echinococcus multilocular have used the dog as an experimental model to
207
investigate the reproductive potency, infectivity and pathogenicity of the parasite, as well
208
as develop vaccines and assess drugs (Petitdidier et al., 2016; Padilla et al., 2009; Kapel
209
et al., 2006; Cedillo et al., 2008;). Here, we established a canine model of infection with
AC C
EP
202
10
ACCEPTED MANUSCRIPT
210
C. canis, with dexamethasone used to develop the experimental model of
211
cryptosporidiosis as in previous reports (Surl and Kim, 2006; Certad et al., 2007). Experimentally inoculated immunocompetent dogs did not produce detectable C.
213
canis oocysts by microscopy in faecal samples within 28 DPI. None of the SCID mice
214
exhibited clinical signs or oocyst shedding at any point during the experiment. It is
215
suspected that SCID mice were not infected with C. canis. Data from a previous study
216
also indicate that oocysts of C. canis were not infectious for BALB/c neonatal mice or
217
immunosuppressed C57 juvenile mice, but were infectious for calves (Fayer et al., 2001).
218
In our study, infected dogs began shedding oocysts in low numbers on day 3 p.i.,
219
with two peaks of infection intensity during the patent period. In immunosuppressed mice
220
infected with C. parvum, oocyst shedding begins 6 days p.i., and these mice continue
221
shedding until day 35 p.i. (Coco et al., 2012). The prepatent period was 4 days in the case
222
of infection in immunosuppressed C57BL/6 mice with a single C. meleagridis oocysts
223
(Huang et al., 2003). However, the prepatent period was 20-24 days, and the patent
224
period varied between 46 and 59 days in neonatal and adult M. coucha infected with C.
225
andersoni (Kvac et al., 2007). The differences in the prepatent and patent period probably
226
depend on the experimental animals or species of Cryptosporidium.
SC
M AN U
TE D
EP
AC C
227
RI PT
212
Variability of infection sites between different Cryptosporidium species and types
228
has been reported (Plutzer and Karanis., 2009). Three of the four spieces of
229
Cryptosporidium (C. canis, C. parvum and C. meleagridis) that infect dogs are detected
230
in the small intestine, except C. muris which is detected in stomach; this difference could 11
ACCEPTED MANUSCRIPT
be associated with different patterns of colonization along the gastrointestinal tract. In
232
this study, cryptosporidial developmental stages were observed in the middle and lower
233
parts of duodenal mucosa epithelium, and anterior and middle parts of jejunal mucosa
234
epithelium in histological sections and SEM study. This is similar to what has been
235
described for naturally-occurring cryptosporidiosis in dogs (Greene et al., 1990; Wilson
236
et al., 1983). However, one published case report indicates that C. canis was found both
237
in the small intestine and gastric surface epithelium of an 8-week-old female Yorkshire
238
terrier co-infected with Isospora spp. (Miller et al., 2003). Extraintestinal infection was
239
not observed in our study, which could be related to the degree of immunosuppression,
240
and/or the time post-infection that we evaluated.
M AN U
SC
RI PT
231
Cryptosporidium primarily infects the microvillous border of the intestinal
242
epithelium, and to lesser extent extraintestinal epithelia, causing acute gastrointestinal
243
disease in a wide range of mammalian hosts, including humans (Deng et al., 2004).
244
Damage of host intestinal epithelial cells caused by cryptosporidiosis usually results in
245
two outcomes: cell death and cell damage. Both produce architecture distortion and
246
atrophy of the villus. In the present study, the surfaces of the epithelial cells were swollen
247
and disordered. The integrity of mucosal layer had been damaged, and many cilia had
248
fallen off atrophied in duodenum and jejunum of dogs infected with C. canis. Similarity,
249
in chickens successfully infected with C. baileyi, the integrity of the epithelial cells of the
250
BF (bursas of fabricius) was somewhat damaged (Yuan et al., 2014). In mice infected
251
with C. parvum, cryptosporidium stages were detected on the brush borders and the
AC C
EP
TE D
241
12
ACCEPTED MANUSCRIPT
252
intestinal epithelium showed loss of single epithelial cells, mild blunting, and shortening
253
of villi (Sayed et al., 2016). In conclusion, we have established an experimental infection of C. canis in dogs
255
immunosuppressed with dexamethasone. Parasitological and histopathological features of
256
the infection were studied. These findings may foster further understanding of the biology
257
of C. canis and lay the foundation to control cryptosporidiosis.
SC
RI PT
254
M AN U
258 259
Conflict of interests
260
The authors declare that there are no conflicts of interest.
261
Acknowledgments
263
This study was partly supported by the National Key Research and Development
264
Program of China (2017YFD0501305, 2016YFD0500707), the National Natural Science
265
Foundation of China (31330079), and the Natural Science Foundation of Henan Province
266
(162300410129).
EP
AC C
267
TE D
262
268
We thank Catherine Barnette, DVM, from Liwen Bianji, Edanz Group China
269
(www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
270 271 272 13
ACCEPTED MANUSCRIPT
References
274
Ayinmode, A. B., Ogbonna, N. F., & Widmer, G. (2017). Detection and molecular
275
identification of Cryptosporidium species in laboratory rats (Rattus norvegicus) in
276
Ibadan, Nigeria. Ann Parasitol, 63(2), 105-109.
278
Bouzid, M., Hunter, P. R., Chalmers, R. M., & Tyler, K. M. (2013). Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev, 26(1), 115-134.
SC
277
RI PT
273
Bukhari, Z., & Smith, H. V. (1995). Effect of three concentration techniques on viability
280
of Cryptosporidium parvum oocysts recovered from bovine feces. J Clin Microbiol,
281
33(10), 2592-2595.
M AN U
279
Cedillo, C. J., Martinez, M. J., Santacruz, A. M., Banda, R. V., & Morales, S. E. (2008).
283
Models for experimental infection of dogs fed with tissue from fetuses and neonatal
284
cattle naturally infected with Neospora caninum. Vet Parasitol, 154(1-2), 151-155.
TE D
282
Certad, G., Ngouanesavanh, T., Guyot, K., Gantois, N., Chassat, T., Mouray, A., . . .
286
Creusy, C. (2007). Cryptosporidium parvum, a potential cause of colic
287
adenocarcinoma. Infect Agent Cancer, 2, 22.
289 290 291
AC C
288
EP
285
Chalmers, R. M., & Davies, A. P. (2010). Minireview: clinical cryptosporidiosis. Exp Parasitol, 124(1), 138-146.
Chomel, B. B. (2014). Emerging and Re-Emerging Zoonoses of Dogs and Cats. Animals (Basel), 4(3), 434-445.
292
Del Coco, V. F., Cordoba, M. A., Sidoti, A., Santin, M., Drut, R., & Basualdo, J. A.
293
(2012). Experimental infection with Cryptosporidium parvum IIaA21G1R1 subtype 14
ACCEPTED MANUSCRIPT
295 296
in immunosuppressed mice. Vet Parasitol, 190(3-4), 411-417. Deng, M., Rutherford, M. S., & Abrahamsen, M. S. (2004). Host intestinal epithelial response to Cryptosporidium parvum. Adv Drug Deliv Rev, 56(6), 869-884.
RI PT
294
Elwin, K., Hadfield, S. J., Robinson, G., & Chalmers, R. M. (2012). The epidemiology of
298
sporadic human infections with unusual cryptosporidia detected during routine
299
typing in England and Wales, 2000-2008. Epidemiol Infect, 140(4), 673-683.
301 302 303
Esch, K. J., & Petersen, C. A. (2013). Transmission and epidemiology of zoonotic
M AN U
300
SC
297
protozoal diseases of companion animals. Clin Microbiol Rev, 26(1), 58-85. Fayer, R. (2010). Taxonomy and species delimitation in Cryptosporidium. Exp Parasitol, 124(1), 90-97.
Fayer, R., Trout, J. M., Xiao, L., Morgan, U. M., Lai, A. A., & Dubey, J. P. (2001).
305
Cryptosporidium canis n. sp. from domestic dogs. J Parasitol, 87(6), 1415-1422.
306
Gatei, W., Barrett, D., Lindo, J. F., Eldemire-Shearer, D., Cama, V., & Xiao, L. (2008).
307
Unique Cryptosporidium population in HIV-infected persons, Jamaica. Emerg Infect
308
Dis, 14(5), 841-843.
310
EP
AC C
309
TE D
304
Greene, C. E., Jacobs, G. J., & Prickett, D. (1990). Intestinal malabsorption and cryptosporidiosis in an adult dog. J Am Vet Med Assoc, 197(3), 365-367.
311
Heyman, M. B., Shigekuni, L. K., & Ammann, A. J. (1986). Separation of
312
cryptosporidium oocysts from fecal debris by density gradient centrifugation and
313
glass bead columns. J Clin Microbiol, 23(4), 789-791.
314
Hodgson, K., Barton, L., Darling, M., Antao, V., Kim, F. A., & Monavvari, A. (2015). 15
ACCEPTED MANUSCRIPT
315
Pets' Impact on Your Patients' Health: Leveraging Benefits and Mitigating Risk. J
316
Am Board Fam Med, 28(4), 526-534. Huang, K., Akiyoshi DEFeng, X. C., & Tzipori, S. (2003). Development of patent
318
infection in immunosuppressed C57BL/6 mice with a single Cryptosporidium
319
meleagridis oocyst. Journal of Parasitology, 89(3), 620-622.
RI PT
317
Jian, F., Meng, Q., He, X., Wang, R., Zhang, S., Dong, H., & Zhang, L. (2014).
321
Occurrence and molecular characterization of Cryptosporidium in dogs in Henan
322
Province, China. BMC Vet Res, 10(1), 26-26.
M AN U
SC
320
Kapel, C. M., Torgerson, P. R., Thompson, R. C., & Deplazes, P. (2006). Reproductive
324
potential of Echinococcus multilocularis in experimentally infected foxes, dogs,
325
raccoon dogs and cats. Int J Parasitol, 36(1), 79-86.
TE D
323
Kvac, M., McEvoy, J., Loudova, M., Stenger, B., Sak, B., Kvetonova, D., . . . Pialek, J.
327
(2013). Coevolution of Cryptosporidium tyzzeri and the house mouse (Mus
328
musculus). Int J Parasitol, 43(10), 805-817.
330 331
Kvac, M., Ondrackova, Z., Kvetonova, D., Sak, B., & Vitovec, J. (2007). Infectivity and
AC C
329
EP
326
pathogenicity
of
Cryptosporidium
andersoni
to
a
novel
host,
southern
multimammate mouse (Mastomys coucha). Vet Parasitol, 143(3-4), 229-233.
332
Lupo, P. J., Langer-Curry, R. C., Robinson, M., Okhuysen, P. C., & Chappell, C. L.
333
(2008). Cryptosporidium muris in a Texas canine population. Am J Trop Med Hyg,
334
78(6), 917-921.
335
Miller, D. L., Liggett, A., Radi, Z. A., & Branch, L. O. (2003). Gastrointestinal 16
ACCEPTED MANUSCRIPT
336
cryptosporidiosis in a puppy. Vet Parasitol, 115(3), 199-204. Modry, D., Hofmannova, L., Antalova, Z., Sak, B., & Kvac, M. (2012). Variability in
338
susceptibility of voles (Arvicolinae) to experimental infection with Cryptosporidium
339
muris and Cryptosporidium andersoni. Parasitol Res, 111(1), 471-473.
341
Padilla, A. M., Bustamante, J. M., & Tarleton, R. L. (2009). CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol, 21(4), 385-390.
SC
340
RI PT
337
Petermann, J., Paraud, C., Pors, I., & Chartier, C. (2014). Efficacy of halofuginone lactate
343
against experimental cryptosporidiosis in goat neonates. Vet Parasitol, 202(3-4),
344
326-329.
M AN U
342
Petitdidier, E., Pagniez, J., Papierok, G., Vincendeau, P., Lemesre, J. L., &
346
Bras-Goncalves, R. (2016). Recombinant Forms of Leishmania amazonensis
347
Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune
348
Responses in Dogs. PLoS Negl Trop Dis, 10(5), e0004614.
351 352 353 354
EP
350
Plutzer, J., & Karanis, P. (2009). Genetic polymorphism in Cryptosporidium species: an update. Vet Parasitol, 165(3-4), 187-199.
AC C
349
TE D
345
Ryan, U., Fayer, R., & Xiao, L. (2014). Cryptosporidium species in humans and animals: current understanding and research needs. Parasitology, 141(13), 1667-1685.
Ryan, U., Zahedi, A., & Paparini, A. (2016). Cryptosporidium in humans and animals-a one health approach to prophylaxis. Parasite Immunol, 38(9), 535-547.
355
Sayed, F. G., Hamza, A. I., Galal, L. A., Sayed, D. M., & Gaber, M. (2016). Virulence of
356
geographically different Cryptosporidium parvum isolates in experimental animal 17
ACCEPTED MANUSCRIPT
357
model. Ann Parasitol, 62(3), 221-232. Scorza, A. V., Duncan, C., Miles, L., & Lappin, M. R. (2011). Prevalence of selected
359
zoonotic and vector-borne agents in dogs and cats in Costa Rica. Vet Parasitol,
360
183(1-2), 178-183.
362
Sulaiman IM, Lal AA, Xiao LH. Molecular phylogeny and evolutionary relationships of Cryptosporidium parasites at the actin locus [J]. J Parasitol, 2002, 88(2):388~394.
SC
361
RI PT
358
Sulaiman IM, Morgan UM, Thompson RC, et al. Phylogenetic relationships of
364
Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70)
365
gene. Appl. Environ Microbiol, 2000, 66(6):2385~2391.
M AN U
363
Surl, C. G., & Kim, H. C. (2006). Concurrent response to challenge infection with
367
Cryptosporidium parvum in immunosuppressed C57BL/6N mice. Journal of
368
Veterinary Science, 7(1), 47-51.
371 372 373 374
Canine gastrointestinal parasitic zoonoses in India. Trends Parasitol, 21(1), 42-48.
EP
370
Traub, R. J., Robertson, I. D., Irwin, P. J., Mencke, N., & Thompson, R. C. (2005).
Wells, D. L. (2007). Domestic dogs and human health: an overview. Br J Health Psychol,
AC C
369
TE D
366
12(Pt 1), 145-156.
Wilson, R. B., Holscher, M. A., & Lyle, S. J. (1983). Cryptosporidiosis in a pup. J Am Vet Med Assoc, 183(9), 1005-1006, 1965.
375
Xiao, L., Escalante, L., Yang, C., Sulaiman, I., Escalante, A. A., Montali, R. J., . . . Lal, A.
376
A. (1999). Phylogenetic analysis of Cryptosporidium parasites based on the
377
small-subunit rRNA gene locus. Appl Environ Microbiol, 65(4), 1578-1583. 18
ACCEPTED MANUSCRIPT
Yoshiuchi, R., Matsubayashi, M., Kimata, I., Furuya, M., Tani, H., & Sasai, K. (2010).
379
Survey and molecular characterization of Cryptosporidium and Giardia spp. in
380
owned companion animal, dogs and cats, in Japan. Vet Parasitol, 174(3-4), 313-316.
RI PT
378
Young, S. L., O’Donnell, M. A., & Buchan, G. S. (2002). IL 2 secreting recombinant
382
bacillus Calmette Guerin can overcome a Type 2 immune response and
383
corticosteroid induced immunosuppression to elicit a Type 1 immune response.
384
International Immunology, 14(7), 793-800.
M AN U
SC
381
385
Yuan, L., Yan, W., Wang, T., Qian, W., Ding, K., Zhang, L., . . . Shao, X. (2014). Effects
386
of different inoculation routes on the parasitic sites of Cryptosporidium baileyi
387
infection in chickens. Exp Parasitol, 145, 152-156.
389 390
Figure legends
TE D
388
Fig. 1. Microscopy of Cryptosporidium canis oocysts visualized by Modified acid-fast
392
staining method (1000×).
AC C
393
EP
391
394
Fig. 2. Excretion of oocysts in one gram of feces in immunosuppressed dogs infected
395
with C. canis during the experiment. Mean of all examined animals with standard errors.
396 397
Fig. 3. Histological observation of C. canis infection in immunosuppressed dogs using H
398
& E staining. High parasite burden in the duodenum (A, ×1000) and jejunum (B, C, 19
ACCEPTED MANUSCRIPT
399
×1000) (arrows). No cryptosporidial developmental stages and pathologic changes were
400
observed in the ileum (D, ×400).
RI PT
401
Fig. 4. Scanning electronic microscopic observation of C. canis infection in
403
immunosuppressed dogs. C. canis at a large number of developmental stage had adhered
404
to the surface of duodenum and jejunum (A, B, ×3000) (arrows). The surfaces of the
405
epithelial cells were swollen and disordered. The integrity of mucosal layer of the
406
duodenum and jejunum had been damaged, and many cilia had fallen off or atrophied (C,
407
D, ×5000).
AC C
EP
TE D
M AN U
SC
402
20
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
AC C
EP
TE D
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
ACCEPTED MANUSCRIPT Highlights · This is the first canine model of experimental infection with C. canis. · C. canis was not infective for immunocompetent dogs and SCID mice. · Cryptosporidial infection was only found in duodenum and jejunum.
AC C
EP
TE D
M AN U
SC
RI PT
· The histopathological changes were observed with HE and SEM.